Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
about
Study of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1Applications of urinary proteomics in biomarker discoveryProteomics and systems biology for understanding diabetic nephropathyCirculating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy.Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure.Soluble E-cadherin: more than a symptom of disease.L1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control studyDefining nephrotic syndrome from an integrative genomics perspective.Epithelial cells as active player in fibrosis: findings from an in vitro model.Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome.Effects of three commonly-used diuretics on the urinary proteome.A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database.Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians.Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases.Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification.Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy.Proteomic approaches for discovering biomarkers of diabetic nephropathy.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy.Body fluid peptide and protein signatures in diabetic kidney diseases.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.E-cadherin gene 3'-UTR C/T polymorphism in Turkish patients with nephrolithiasis.MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.A Micro-Scale Model to Monitor the Major Proteins in Human Urine Before and After Medication with Angiotensin-Converting Enzyme Inhibitor: A Preliminary Study
P2860
Q26798146-51096D83-9073-48EF-9C12-21FDD6514796Q27010368-1465BED8-5016-4E09-B537-DED034FD750CQ28728631-363FC312-C392-4F74-A9E0-27E461DA770BQ30277225-B7CFCDBE-D0CE-4038-9619-F3F62259232CQ30883079-2A0A13A8-E27E-4626-BF4C-812E80512C98Q33781011-6A01D82C-C0EC-444F-B158-43859B5DC427Q34115491-2469A2E5-7B44-4B4D-8C69-E992F639E083Q34172662-DD574F69-C66D-4F6E-8EFA-D1366014E995Q34279705-C6A138B5-E0DF-425A-8C1D-013AE3CA3535Q34305634-D6E8704B-3DF6-411B-9A8B-75AEB0E2E074Q34560989-C695739B-34C7-4546-A98C-4D17068DFCEDQ34606895-F62C4D74-7B10-4F7F-ABF8-EF65F304B618Q35000828-30C49181-B8B0-4DE9-84AE-5A9946AC4804Q35054853-8881B33D-CB96-45E8-A70E-043F8CB8CF4CQ35184085-AD63BC41-B4D7-4CDD-90CA-96AEFB01D9EBQ35543587-2C9A301C-14DA-4C58-96A5-DD0BE1E67C50Q35579632-FA28336B-1555-4301-A6B1-CDCB0EEF4A0CQ35997377-8246CCEE-28FF-4C77-8152-BA50ACC143B7Q36141289-058C9CDE-5CD5-4BCE-AD07-A358E05A4416Q36321624-DF5E4B9B-569F-4F3D-BB6C-536ADD01B060Q37434486-0C98ED54-B229-401C-8B24-76581ECEFA82Q37753489-215C5BEA-242C-430A-94CE-F5B62FCEA992Q38045278-B4F379F5-25B9-47C9-815F-484828163389Q38053941-3420B825-0E0F-4B5D-85D8-E6279AE5BAA1Q38114159-A264A977-7B92-4F7A-831F-15FB38579364Q38553924-199A29BF-5280-4EA5-ACEF-5B905710C1D5Q38961899-F3CB8804-75C4-44FD-A640-8B070BB93120Q54397109-B6A997B7-8CA8-4BA6-9E4A-B2C33974CFB1Q54959769-DE2AD80F-6EDB-4BC4-8EC3-039CE8CF4316Q58309332-E68E9676-049D-4E86-A4B0-3D973A9F222D
P2860
Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification of urinary solu ...... rker for diabetic nephropathy.
@ast
Identification of urinary solu ...... rker for diabetic nephropathy.
@en
type
label
Identification of urinary solu ...... rker for diabetic nephropathy.
@ast
Identification of urinary solu ...... rker for diabetic nephropathy.
@en
prefLabel
Identification of urinary solu ...... rker for diabetic nephropathy.
@ast
Identification of urinary solu ...... rker for diabetic nephropathy.
@en
P2093
P2860
P356
P1476
Identification of urinary solu ...... rker for diabetic nephropathy.
@en
P2093
Guangju Guan
Hongjuan Jiang
Jing Cheng
Xianghua Hou
P2860
P304
P356
10.1002/DMRR.940
P50
P577
2009-03-01T00:00:00Z